Table: RaQualia Pharma - 6-MTH group results

RaQualia Pharma

10/08/2023 07:30

Aug 10 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2023        Jun 30, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.01                1.45             2.80     
                   (-29.9 pct)         (+9.6 pct)       (-4.1 pct)  
  Operating        loss 23 mln           551 mln          260 mln   
                                       (+75.1 pct)      (-69.9 pct) 
  Recurring          36 mln              681 mln          242 mln   
                   (-94.6 pct)         (+57.4 pct)      (-73.2 pct) 
  Net                25 mln              469 mln          183 mln   
                   (-94.6 pct)         (+55.0 pct)      (-74.7 pct) 
  EPS               1.18 yen            22.40 yen        8.74 yen   
  EPS Diluted       1.18 yen            22.39 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T